Home > News > Headline News > Archive

Click on title to read the full article.

Targeted Drug Slows Breast Cancer Progression

May 29, 2010

By Charles Bankhead, Med Page Today

Women with advanced breast cancer had significant improvement in progression-free survival when bevacizumab (Avastin) was added to docetaxel (Taxotere), investigators in a multicenter clinical trial reported.

Desperately Seeking Cures - How the road from promising scientific breakthrough to real-world remedy has become all but a dead e

May 16, 2010

By Mary Carmichael and Sharon Begley, Newsweek

June 1st, 2010

From 1996 to 1999, the U.S. food and Drug Administration approved 157 new drugs. In the comparable period a decade later—that is, from 2006 to 2009—the agency approved 74. Not among them were any cures, or even meaningfully effective treatments, for Alzheimer’s disease, lung or pancreatic cancer, Parkinson’s disease, Huntington’s disease, or a host of other afflictions that destroy lives.

Stereotactic Radiosurgery Effective, Safe in Select Patients With Brain Metastases From Breast Cancer: Presented at AANS

May 7, 2010

By DocGuide.com

PHILADELPHIA —  Stereotactic radiosurgery (SRS) is safe and effective for select patients with brain metastases from breast cancer, researchers said here on May 4 at the 2010 Annual Meeting of the American Association of Neurological Surgeons (AANS).

ASCO/CAP issue hormone receptor testing guidelines

May 4, 2010

By HemOncToday.com

The American Society of Clinical Oncology and the College of American Pathologists cooperatively released a guideline aimed at improving the accuracy of immunohistochemistry testing in patients with breast cancer for their estrogen receptor and progesterone receptor expression status